TrialDiabetes technology & therapeutics2020

Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 Diabetes.

Christoph Kapitza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.